Oncotarget

Vol 10, No 50

August 27, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 50 of Oncotarget features Figure 3, "The effects of variables found in routine clinical testing on the precision of MSI NGS calls," by Pabla, et al.

Table of Contents

Editorial

Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene

Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene

https://doi.org/10.18632/oncotarget.27154

Tibor Bedekovics, Sajjad Hussain,  and Paul J. Galardy
5124-5125
PDF  |  How to cite  |  Order a Reprint

Research Perspectives

Ras functional proximity proteomics establishes mTORC2 as new direct ras effector

Ras functional proximity proteomics establishes mTORC2 as new direct ras effector

https://doi.org/10.18632/oncotarget.27025

Joanna R. Kovalski, Ronald L. Shanderson,  and Paul A. Khavari
5126-5135
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Research Papers

Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma

Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma

https://doi.org/10.18632/oncotarget.27098

Luís Alberto de Pádua Covas Lage, Débora Levy, Flávia Dias Xavier, Diego Cândido Reis, Renata de Oliveira Costa, Marianne Castro Gonçalves, Vanderson Rocha, Maria Cláudia Nogueira Zerbini,  and Juliana Pereira
5136-5151
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model

DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model

https://doi.org/10.18632/oncotarget.27114

Takeshi Jimbo, Mana Hatanaka, Takahiro Komatsu, Tomoe Taira, Kentaro Kumazawa, Naoyuki Maeda, Takashi Suzuki, Masahiro Ota, Noriyasu Haginoya, Takeshi Isoyama,  and Kosaku Fujiwara
5152-5167
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A

Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A

https://doi.org/10.18632/oncotarget.27125

Jennifer Bourn, Sony Pandey, Jashim Uddin, Lawrence Marnett,  and Maria Cekanova
5168-5180
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assay

Development and analytical validation of a next-generation sequencing based microsatellite instability (MSI) assay

https://doi.org/10.18632/oncotarget.27142

Sarabjot Pabla, Jonathan Andreas, Felicia L. Lenzo, Blake Burgher, Jacob Hagen, Vincent Giamo, Mary K. Nesline, Yirong Wang, Mark Gardner, Jeffrey M. Conroy, Antonios Papanicolau-Sengos, Carl Morrison,  and Sean T. Glenn
5181-5193
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma

Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma

https://doi.org/10.18632/oncotarget.27146

Catrin Tauber, Michael Schultheiss, Raffaele De Luca, Nico Buettner, Sian Llewellyn-Lacey, Florian Emmerich, Sebastian Zehe, David A. Price, Christoph Neumann-Haefelin, Annette Schmitt-Graeff, Maike Hofmann,  and Robert Thimme
5194-5206
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy

Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy

https://doi.org/10.18632/oncotarget.27147

Satoshi Tsunetoh, Yoshito Terai, Masaaki Takai, Satoe Fujiwara, Yoshimichi Tanaka, Tomohito Tanaka, Hiroshi Sasaki, Naokazu Ibuki, Takanobu Ubai, Kazuhiro Yamamoto, Haruhito Azuma,  and Masahide Ohmichi
5207-5216
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Increased expression of cathepsin D is required for L1-mediated colon cancer progression

Increased expression of cathepsin D is required for L1-mediated colon cancer progression

https://doi.org/10.18632/oncotarget.27155

Sayon Basu, Sanith Cheriyamundath, Nancy Gavert, Thomas Brabletz, Gal Haase,  and Avri Ben-Ze’ev
5217-5228
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma

https://doi.org/10.18632/oncotarget.27156

Jennifer Bryant, Nikolaos Batis, Anna Clara Franke, Gabriella Clancey, Margaret Hartley, Gordon Ryan, Jill Brooks, Andrew D. Southam, Nicholas Barnes, Joanna Parish, Sally Roberts, Farhat Khanim, Rachel Spruce,  and Hisham Mehanna
5229-5244
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Clinical Research Papers

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database

https://doi.org/10.18632/oncotarget.24703

Jie Zhang, Xiao-Xiao Wang, Jun-Yu Lian,  and Chuan-Gui Song
5245-5252
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer

Correction: Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer

https://doi.org/10.18632/oncotarget.27174

Yang Jin, Zilian Cui, Xudong Li, Xunbo Jin,  and Jian Peng
5253-5253
Correction  |  PDF  |  How to cite

Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory

Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory

https://doi.org/10.18632/oncotarget.27176

Natalia Paez Arango, Lauren Brusco, Kenna R. Mills Shaw, Ken Chen, Agda Karina Eterovic, Vijaykumar Holla, Amber Johnson, Beate Litzenburger, Yekaterina B. Khotskaya, Nora Sanchez, Ann Bailey, Xiaofeng Zheng, Chacha Horombe, Scott Kopetz, Carol J. Farhangfar, Mark Routbort, Russell Broaddus, Elmer V. Bernstam, John Mendelsohn, Gordon B. Mills,  and Funda Meric-Bernstam
5254-5254
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC